Back to Search
Start Over
A novel, selective and orally-available glucosylceramide synthase inhibitor for substrate reduction therapy of Fabry disease
- Source :
-
Molecular Genetics & Metabolism . Feb2013, Vol. 108 Issue 2, pS20-S20. 1p. - Publication Year :
- 2013
Details
- Language :
- English
- ISSN :
- 10967192
- Volume :
- 108
- Issue :
- 2
- Database :
- Academic Search Index
- Journal :
- Molecular Genetics & Metabolism
- Publication Type :
- Academic Journal
- Accession number :
- 85156252
- Full Text :
- https://doi.org/10.1016/j.ymgme.2012.11.026